Articles tagged "Multivisceral transplantation"

2021 American Transplant Congress
Clinical Characteristics and Outcomes of Aspergillus Infections in Intestinal Transplant Patients: Retrospective Cohort Study
A. Fernandez, M. Romero, Y. Natori, J. Camargo, S. Anjan, R. Vianna, J. Simkins
Miami Transplant Institute, Jackson Health System, Miami, FL
*Purpose: Aspergillus infection is the most common mold infection in solid organ transplant recipients and its consequences can be fatal. Data in intestinal transplants (ITx)…
2021 American Transplant Congress
Survival After Heart Transplant vs. Simultaneous Heart Kidney Transplant by Degrees of Renal Dysfunction at Engraftment in the United States: A Multivariable Analysis
S. M. Riad¹, M. Aljuhani¹, S. Jackson², T. Alexy¹, H. Wadie³, C. Martin¹, R. Kandaswamy⁴
¹Medicine, University of Minnesota, Eden Prairie, MN, ²Complex Care Analytics, Fairview Health Services, Minneapolis, MN, ³Transplant, Mayo Clinic, Jacksonville, FL, ⁴Surgery, University of Minnesota, Minneapolis, MN
*Purpose: There has been a rising trend for utilizing kidneys in heart transplant candidates with different renal dysfunction degrees without established criteria to address this…
2020 American Transplant Congress
Long-Term Pediatric Outcomes of Simultaneous vs. Sequential Liver-Kidney Transplantation: A Review of the UNOS Database
K. Goli¹, A. Rana¹, J. Goss¹, T. Miloh²
¹Baylor College of Medicine/Texas Children's Hospital, Houston, TX, ²University of Miami, Houston, TX
*Purpose: The long-term pediatric outcomes of simultaneous liver-kidney (SLK) transplantation and sequential liver and kidney transplantation, liver after kidney (LAK) and kidney after liver (KAL),…
2020 American Transplant Congress
Effects of Donor Specific Antibodies in Intestinal/Multivisceral Transplant Recipients
K. Klein¹, M. Keck², E. Langewisch², S. Merani², M. Leick²
¹University Health System, San Antonio, TX, ²Nebraska Medicine, Omaha, NE
*Purpose: Evaluate the effects of donor specific antibodies (DSAs) on outcomes in post-intestinal/multivisceral (MV) transplant patients and describe the presentation of DSAs post-transplant.*Methods: This single-center…
2020 American Transplant Congress
Role of B-Cell Subsets in Allograft Rejection in Intestinal Transplantation
H. Dhani, N. Svetlicky, J. Kang, S. Moturi, A. Duttargi, K. Khan, C. Matsumoto, T. Fishbein, A. Kroemer
Transplant Institute, MedStar Georgetown University, Washington, DC
*Purpose: While B-cells contribute to allograft rejection by presenting antigens to T-cells and by producing donor-specific antibodies (DSAs) and various cytokines, their pathophysiology in transplant…
2020 American Transplant Congress
Trends in Intestinal and Multivisceral Transplantation in the United States over 30 Years
M. L. Samoylova¹, J. Yerxa¹, B. I. Shaw¹, S. Horslen², S. Jafri³, A. Mavis⁴, T. Schiano⁵, B. Summers⁶, A. S. Barbas¹, D. L. Sudan¹, M. C. Segovia⁴
¹Surgery, Duke University Hospital, Durham, NC, ²Ped Gastroenterology, Seattle Childrens' Hospital, Seattle, WA, ³Gastroenterology, Henry Ford Hospital, Detroit, MI, ⁴Gastroenterology, Duke University Hospital, Durham, NC, ⁵Gastroenterology, Mt Sinai Hospital, New York, NY, ⁶Transplant Pharmacy, Henry Ford Hospital, Detroit, MI
*Purpose: We describe trends in intestinal transplantation use and outcomes over time in the USA.*Methods: We use the cohort of intestinal and multivisceral transplants 1990-2019…
2020 American Transplant Congress
Role of APC Subsets in Rejection and Graft-Versus-Host-Disease in Intestinal Transplantation
H. Dhani, N. Svetlicky, J. Kang, S. Moturi, A. Duttargi, K. Khan, C. Matsumoto, T. S. Fishbein, A. Kroemer
Transplant Institute, MedStar Georgetown University, Washington, DC
*Purpose: Intestinal transplantation (ITx) is arguably the most immunogenic and complex organ transplantation, often accompanied with high rates of allograft rejection (AR) and graft-versus-host disease…
2020 American Transplant Congress
Combined Heart-Liver Transplantation Has Excellent Long-Term Outcomes
J. A. Steadman¹, J. M. Stulak¹, A. L. Clavell², S. S. Kushwaha², B. S. Edwards², N. L. Pereira², B. A. Boilson², A. Behfar², R. J. Rodeheffer², J. A. Dearani¹, T. Taner³, R. C. Daly¹
¹Division of Cardiovascular Surgery, Mayo Clinic, Rochester, MN, ²Division of Cardiovascular Disease, Mayo Clinic, Rochester, MN, ³Division of Transplantation Surgery, Mayo Clinic, Rochester, MN
*Purpose: Combined heart-liver transplants (CHLTx) have been shown to have good short-term outcomes in those with end-stage heart and liver disease: we conducted a comprehensive…
2020 American Transplant Congress
Belatacept in Kidney Transplant Recipients with Previous Non-Renal Solid Organ Transplants
O. Cristea, C. Larsen, I. Badell
Emory Transplant Center, Emory University School of Medicine, Atlanta, GA
*Purpose: Selective co-stimulatory blockade with belatacept has demonstrated long-term benefits in renal transplantation, with improved glomerular filtration rate and decreased risk of death and graft…
2020 American Transplant Congress
Perioperative Extracorporeal Membrane Oxygenation (ECMO) in Liver Transplantation: A Case Series
J. G. Guorgui¹, T. Ito¹, M. M. Lu¹, P. Benharash², A. Ardehali³, V. Gudzenko⁴, C. Wray⁴, V. G. Agopian¹, J. DiNorcia III¹, H. Yersiz¹, D. G. Farmer¹, R. W. Busuttil¹, F. M. Kaldas¹
¹The Dumont-UCLA Transplant Center, UCLA, Los Angeles, CA, ²Cardiovascular Outcomes Research Laboratories, UCLA, Los Angeles, CA, ³Division of Cardiac Surgery, Department of Surgery, UCLA, Los Angeles, CA, ⁴Department of Anesthesiology, UCLA, Los Angeles, CA
*Purpose: Extracorporeal Membrane Oxygenation (ECMO) is a life-saving treatment modality for patients who develop cardiopulmonary failure refractory to conventional efforts. ECMO has been used sparingly…